Concomitant use of clopidogrel and proton pump inhibitors and major adverse cardiovascular events following coronary stent implantation

被引:0
|
作者
Schmidt, Morten [1 ,2 ]
Johansen, Martin B. [1 ]
Robertson, Douglas J. [4 ,5 ]
Maeng, Michael [2 ]
Kaltoft, Anne [2 ]
Jensen, Lisette O. [6 ]
Tilsted, Hans-Henrik [7 ]
Botker, Hans Erik [2 ]
Sorensen, Henrik Toft [1 ]
Baron, John A. [3 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark
[3] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA
[4] VA Med Ctr, White River Jct, VT USA
[5] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
[6] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark
[7] Aarhus Univ Hosp, Dept Cardiol, Aalborg, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B18 / B18
页数:1
相关论文
共 50 条
  • [1] Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation
    Schmidt, M.
    Johansen, M. B.
    Robertson, D. J.
    Maeng, M.
    Kaltoft, A.
    Jensen, L. O.
    Tilsted, H. -H.
    Botker, H. E.
    Sorensen, H. T.
    Baron, J. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (01) : 165 - 174
  • [2] Concomitant Clopidogrel and Statin Use and Risk of Major Adverse Cardiovascular Events Following Coronary Stent Implantation
    Schmidt, Morten
    Johansen, Martin B.
    Maeng, Michael
    Kaltoft, Anne
    Jensen, Lisette O.
    Tilsted, Hans-Henrik
    Botker, Hans E.
    Baron, John A.
    Sorensen, Henrik T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B15 - B15
  • [3] Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation
    Schmidt, Morten
    Johansen, Martin B.
    Maeng, Michael
    Kaltoft, Anne
    Jensen, Lisette O.
    Tilsted, Hans-Henrik
    Botker, Hans E.
    Baron, John A.
    Sorensen, Henrik Toft
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) : 161 - 170
  • [4] Risk of Adverse Cardiovascular Events with Concomitant Use of Proton Pump Inhibitors and Clopidogrel: A Meta-Analysis
    Shukla, Ashish
    Shukla, Sandhya
    Paris, Joseph A.
    Boden, William E.
    CIRCULATION, 2010, 122 (21)
  • [5] Concomitant use of clopidogrel and proton pump inhibitors is not associated with an increased risk of coronary events
    Garcia Rodriguez, L. A.
    Cea-Soriano, L.
    Johansson, S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 415 - 415
  • [6] Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
    Ho, P. Michael
    Maddox, Thomas M.
    Wang, Li
    Fihn, Stephan D.
    Jesse, Robert L.
    Peterson, Eric D.
    Rumsfeld, John S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (09): : 937 - 944
  • [7] Risk of Adverse Clinical Outcomes with Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Percutaneous Coronary Intervention
    Ekta Gupta
    Darpan Bansal
    John Sotos
    Kevin Olden
    Digestive Diseases and Sciences, 2010, 55 : 1964 - 1968
  • [8] Risk of Adverse Clinical Outcomes with Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Percutaneous Coronary Intervention
    Gupta, Ekta
    Bansal, Darpan
    Sotos, John
    Olden, Kevin
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (07) : 1964 - 1968
  • [9] Risk of Adverse Clinical Outcomes with Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Percutaneous Coronary Intervention
    Gupta, Ekta
    Olden, Kevin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S405 - S405
  • [10] Combination Use of Clopidogrel and Proton Pump Inhibitors Increases Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis
    Niu, Qiang
    Wang, Zhongsu
    Zhang, Yong
    Wang, Jiangrong
    Zhang, Pei
    Wang, Cong
    Yin, Xiangcui
    Hou, Yinglong
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (02) : 142 - 152